{"id":"https://openalex.org/W2000854054","doi":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","title":"Venlafaxine in children and adolescents with attention deficit hyperactivity disorder","display_name":"Venlafaxine in children and adolescents with attention deficit hyperactivity disorder","alternate_titles":[],"publication_year":2003,"publication_date":"2003-12-17","ids":{"openalex":"https://openalex.org/W2000854054","doi":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","mag":"2000854054","pmid":"https://pubmed.ncbi.nlm.nih.gov/14678464"},"language":"en","primary_location":{"id":"doi:10.1111/j.1440-1819.2004.01199.x","doi":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000854054"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011487554","display_name":"Nahit Motavall\u0131 Mukaddes","orcid":"https://orcid.org/0000-0001-5846-616X","observed_orcids":["https://orcid.org/0000-0001-5846-616X"]},"institutions":[{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"NAHIT MOTAVALLI MUKADDES","raw_affiliation_strings":["Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey. nmotavalli@yahoo.com","Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey. nmotavalli@yahoo.com","institution_ids":["https://openalex.org/I67581229"]},{"raw_affiliation_string":"Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey","institution_ids":["https://openalex.org/I67581229"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055662772","display_name":"Osman Abal\u0131","orcid":"https://orcid.org/0000-0003-4842-7049","observed_orcids":["https://orcid.org/0000-0003-4842-7049"]},"institutions":[{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"OSMAN ABALI","raw_affiliation_strings":["Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istanbul University, Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul, Turkey","institution_ids":["https://openalex.org/I67581229"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5011487554"],"corresponding_institution_ids":["https://openalex.org/I67581229"],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":null,"fwci":1.8135,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.83126315,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"58","issue":"1","first_page":"92","last_page":"95"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":1.0},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.824999988079071},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8849999904632568},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.7559999823570251},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.7300000190734863},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.7950000166893005},{"id":"https://openalex.org/keywords/clinical-global-improvement","display_name":"Clinical Global Improvement","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9091047048568726},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.7677852511405945},{"id":"https://openalex.org/C2994409691","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit disorder","level":2,"score":0.5027120113372803},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4595772922039032},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4398890435695648},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3696659207344055},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.09837532043457031},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.07421514391899109}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1440-1819.2004.01199.x","doi":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1440-1819.2004.01199.x","pdf_url":null,"source":{"id":"https://openalex.org/S111042112","display_name":"Psychiatry and Clinical Neurosciences","issn_l":"1323-1316","issn":["1323-1316","1440-1819"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Neurosciences","raw_type":"journal-article"},{"id":"pmid:14678464","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14678464","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and clinical neurosciences","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W635680919","https://openalex.org/W1980853310","https://openalex.org/W2001478770","https://openalex.org/W2026664289","https://openalex.org/W2031134409","https://openalex.org/W2064396657","https://openalex.org/W2206837868","https://openalex.org/W2312765868","https://openalex.org/W2317765335","https://openalex.org/W2419001578","https://openalex.org/W2461394289","https://openalex.org/W4281687410"],"related_works":["https://openalex.org/W2001478770","https://openalex.org/W2148861040","https://openalex.org/W2157403660","https://openalex.org/W2206837868","https://openalex.org/W2091916752","https://openalex.org/W2375472129","https://openalex.org/W1953020925","https://openalex.org/W2207106355","https://openalex.org/W2461394289","https://openalex.org/W2167557012"],"abstract_inverted_index":{"The":[0,67],"primary":[1],"purpose":[2],"of":[3,12,17,31,58,86,98,113,156,162,194],"this":[4],"study":[5],"was":[6,33,53,100,105,174],"to":[7,64,120,168,176],"describe":[8],"tolerability":[9],"and":[10,19,38,48,61,71,82,127,147,197],"efficacy":[11],"venlafaxine":[13,32,99,185],"in":[14,35,108,191],"the":[15,84,87,93,110,114,128,166,172,177,192],"treatment":[16,193],"children":[18,37,196],"adolescents":[20,39,198],"with":[21,46,199],"attention":[22],"deficit":[23],"hyperactivity":[24],"disorder":[25],"(ADHD).":[26],"A":[27],"6-week":[28,88],"open":[29],"trial":[30],"conducted":[34],"13":[36],"(mean":[40],"age":[41],"9.9":[42],"+/-":[43,102],"2.5":[44],"years)":[45],"ADHD,":[47],"without":[49],"comorbid":[50],"depression.":[51],"Venlafaxine":[52,104],"initiated":[54],"at":[55,80,83],"a":[56],"dose":[57,97,167,173],"18.75":[59],"mg/day":[60],"flexibly":[62],"titrated":[63],"56.25":[65],"mg/day.":[66],"Conners":[68,115],"parent":[69,116],"scale":[70,117],"Clinical":[72],"Global":[73],"Improvement":[74],"(CGI)":[75],"severity":[76,130],"item":[77,131],"were":[78],"performed":[79],"baseline":[81,119],"end":[85],"trial.":[89,94],"All":[90],"subjects":[91,160],"completed":[92],"Mean":[95],"final":[96],"40.3":[101],"7.0.":[103],"significantly":[106],"effective":[107,189],"reducing":[109],"total":[111],"score":[112],"from":[118],"endpoint":[121],"(P":[122,132],"<":[123,133],"0.002,":[124],"Z":[125],"=-3.113)":[126],"CGI":[129],"0.05).":[134],"Transient":[135],"side-effects":[136],"such":[137],"as":[138],"somnolence":[139],"(n":[140,144,149],"=":[141,145,150],"2),":[142,146],"stomachache":[143],"headache":[148],"1)":[151],"disappeared":[152],"after":[153,164],"second":[154],"week":[155],"treatment.":[157],"Also":[158],"three":[159],"complained":[161],"sedation":[163],"raising":[165],"56.5":[169],"mg/day,":[170],"therefore":[171],"reduced":[175],"previous":[178],"level.":[179],"These":[180],"preliminary":[181],"data":[182],"suggest":[183],"that":[184],"may":[186],"be":[187,206],"an":[188],"medication":[190],"some":[195],"ADHD.":[200],"Future":[201],"double-blind":[202],"controlled":[203],"trials":[204],"should":[205],"undertaken.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000854054","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
